首页> 美国卫生研究院文献>BMJ Case Reports >Persistent viral shedding despite seroconversion in a kidney transplant recipient with severe extrapulmonary COVID-19
【2h】

Persistent viral shedding despite seroconversion in a kidney transplant recipient with severe extrapulmonary COVID-19

机译:持续的病毒脱落尽管肾脏移植受体中的血清转化具有严重的外肺科卫生间 - 19

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Renal transplant (RT) recipients are at increased risk for infectious complications. The clinical course of COVID-19 has been described in several RT recipients with varying clinical outcomes. Most present with pulmonary manifestations, however extrapulmonary presentations are not uncommon. Also, the timing and efficacy of seroconversion in transplant recipients is not well known. This report describes the duration of viral shedding and timing of seroconversion in a young adult RT recipient with COVID-19 who presented with severe diarrhoea and acute kidney injury requiring dialysis. She developed anti‐SARS‐CoV‐2 IgG antibody after 5 weeks despite persistently shedding the virus in the nasopharynx until 6 weeks after symptom onset. Further studies are needed to determine if immunosuppressed patients have prolonged viral shedding and are still contagious despite seroconversion.
机译:肾移植(RT)受者的感染性并发症的风险增加。 Covid-19的临床过程已在几种RT接受者中描述,临床结果不同。最多存在具有肺部表现的,然而胶质介绍并不少见。而且,移植受体中血清转化的定时和功效是不公知的。本报告描述了在患有严重腹泻和急性肾损伤的Covid-19中的年轻成人RT受体中血清转化的病毒脱落和血清转化的时间持续时间。尽管持续脱落鼻咽在鼻咽悬浮到症状发作后6周后,她在5周后开发了抗SARS-COV-2 IgG抗体。需要进一步的研究来确定免疫抑制的患者是否延长病毒脱落,尽管血清转换仍然存在困难。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号